Abstract
The effective stimulation of lymphocytes by antigen has three potential outcomes for antigen-specific clones, their replication leading to net expansion of cell numbers, their differentiation into effector cells and their differentiation into memory cells. The coordination of these cellular responses is important because, as in other cellular systems, differentiation to the effector stage of development may be associated with an inability to replicate further. For B lymphocytes, terminal differentiation is coupled to cessation of mitosis since non-transformed plasma cells cannot re-enter the cell cycle; it is not clear if terminally differentiated effector T cells have a similar limitation. Therefore, in the immune sytem where the number of antigen-specific clones in a naïve individual is low, premature terminal differentiation occurring before sufficient cellular replication has been achieved would limit the effectiveness of an immune response. Yet, the need for clonal expansion must be appropriately balanced with the obvious benefits of early control and elimination of the infectious process by differentiated lymphocytes. Finally, control of effector cell differentiation and function in the immune system may protect the individual from autoimmune or allergic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.T. Opferman, B.T. Ober, and P.G. Ashton-Rickardt, 1999, Linear differentiation of cytotoxic effectors into memory T lymphocytesScience283, 1745–1748.
C.A. Turner, Jr., D.H. Mack, M.M. Davis, 1994, Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulinsecreting cells, Cell 77, 297–306.
J.F. Piskurich, K.I. Lin, Y. Lin, Y. Wang, J.P. Ting, and K. Calame, 2000, BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cellsNat. Immunol.1, 526–532.
Y. Lin, K. Wong, and K. Calame, 1997, Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiationScience276, 596–599.
P. D. Hodgkin, J. H. Lee, and A.B. Lyons, 1996, B cell differentiation and isotype switching is related to division cycle numberJ. Exp. Med. 184,277–281.
S.M. Kaech, and R. Ahmed, 2001, Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cellsNat. Immunol2, 415–422.
M.J. van Stipdonk, E.E. Lemmens, and S.P. Schoenberger, 2001, Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiationNat. Immunol. 2,423–429.
B.W. Baron, G. Nucifora, N. McCabe, R. Espinosa III, M.M. Le Beau, and T.W. McKeithan, 1993, Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(g27;g11) in B-cell lymphomasProc. Natl. Acad. Sci. USA 90,5262–5266.
J.P. Kerckaert, C. Deweindt, H. Tilly, S. Quief, G. Lecocq, and C. Bastard, 1993, LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas.Nature Genet.5, 66–70.
B.H. Ye, F. Lista, F. Lo Coco, D.M. Knowles, K. Offit, R.S. Chaganti, and R. Dalla-Favera, 1993, Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphomaScience 262,747–750.
C. Deweindt, J.P. Kerckaert, H. Tilly, S. Quief, V.C. Nguyen, and C. Bastard, 1993, Cloning of a breakpoint cluster region at band 3q27 involved in human non-Hodgkin’s lymphoma.Genes Chromosomes Cancer 8,149–154.
T. Miki, N. Kawamata, A. Arai, K. Ohashi, Y. Nakamura, A. Kato, S. Hirosawa, and N. Aoki, 1994, Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemiasBlood 83,217–222.
P. Dhordain, O. Albagli, R.J. Lin, S. Ansieau, S.S. Quief S.A. Leutz A.J.P. Kerckaert, R.M. Evans, and D. Leprince, 1997, Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoproteinProc. Natl. Acad. Sci. USA 94,10762–10767.
P. Dhordain, R.J. Lin, S. Quief, D. Lantoine, J.P. Kerckaert, R.M. Evans, O. Albagli, 1998, The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repressionNucleic Acids Res. 26,4645–4651.
K.D. Huynh, and V.J. Bardwell, 1998, The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRTOncogene 17,2473–2484.
C.W. Wong, and M.L. Privalsky, 1998, Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6J. Biol. Chem. 273,27695–27702
K.F. Ahmad, C.K. Engel, and G.G. Prive GG, 1998, Crystal structure of the BTB domain from PLZFProc. Natl. Acad. Sci. USA 95,121231212–8
X. Li, H. Peng, D.C. Schultz, J.M. Lopez-Guisa, F.J. Rauscher, 3rd, and R. Marmorstein, 1999, Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoproteinCancer Res. 59,5275–5282.
A. Klug, 1999, Zinc finger peptides for the regulation of gene expression, J.Mol. Biol. 293,215–218.
S.A. Wolfe, L. Nekludova, and C.O. Pabo, 2000, DNA recognition by Cys2His2 zinc finger proteinsAnnu. Rev. Biophys. Biomol. Struct. 29,183–212.
N. Kawamata, T. Miki, K. Ohashi, K. Suzuki, T. Fukuda, S. Hirosawa, and N. Aoki, 1994, Recognition DNA sequence of a novel putative transcription factor, BCL6Biochem. Biophys. Res. Commun. 204,366–374.
B.W. Baron, R.R. Stanger, E. Hume, A. Sadhu, R. Mick, J.P. Kerckaert, C. Deweindt, C. Bastard, G. Nucifora, and N. Zeleznik-Le, 1995, BCL6 encodes a sequence-specific DNA-binding protein.Genes Chromosomes Cancer 13,221–224.
C.C. Chang, B.H. Ye, R.S. Chaganti, and R. Dalla-Favera, 1996, BCL-6, a POZ/zincfinger protein, is a sequence-specific transcriptional repressorProc. Natl. Acad. Sci. USA 93,6947–6952.
V.L. Seyfert, D. Allman, Y. He, and L.M. Staudt, 1996, Transcriptional repression by the proto-oncogene BCL-6Oncogene 12,2331–2342.
A.L. Dent, A.L. Shaffer, X. Yu, D. Allman, and L.M. Staudt, 1997, Control of inflammation, cytokine expression, and germinal center formation by BCL-6Science276, 589–592.
M.B. Harris, C.C. Chang, M.T. Berton, N.N. Danial, J. Zhang, D. Kuehner, B.H. Ye, M. Kvatyuk, P.P. Pandolfi, G. Cattoretti, R. Dalla-Favera, and P.B. Rothman, 1999, Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switchingMol. Cell Biol.19, 7264–7275.
T. Hartatik, S. Okada, S. Okabe, M. Arima, M. Hatano, and T. Tokuhisa, 2001, Binding of BAZF and Bc16 to STAT6-binding DNA sequencesBiochem. Biophys. Res. Commun. 284,26–32.
R. Reljic, S.D. Wagner, L.J. Peakman, and D.T. Fearon DT, 2000, Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6J. Exp. Med. 192,1841–1848.
T. Onizuka, M. Moriyama, T. Yamochi, T. Kuroda, A. Kazama, N. Kanazawa, K. Sato, T. Kato, H. Ota, and S. Mori, 1995, BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterpartsBlood 86,28–37.
G. Cattoretti, C.C. Chang, K. Cechova, J. Zhang, B.H. Ye, B. Falini, D.C. Louie,K. Offit, R.S. Chaganti, and R. Dalla-Favera, 1995, BCL-6 protein is expressed in germinal-center B cellsBlood 86,45–53.
L. Flenghi, B.H. Ye, M. Fizzotti, B. Bigerna, G. Cattoretti, S. Venturi, R. Pacini, S. Pilen, F. Lo Coco, and E. Pescarmona, 1995, A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cellsAm. J. Pathol.147, 405–411.
H. Niu, B.H. Ye, and R. Dalla-Favera, 1998, Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factorGenes Dell. 12,1953–1961.
B.H. Ye, G. Cattoretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. NouriShirazi, A. Orazi, R.S. Chaganti, P. Rothman, A.M. Stall, P.P. Pandolfi, and R. Dalla-Favera, 1997, The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammationNat. Genet. 16,161–170.
T. Fukuda, T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, N. Miyasaka, and T. Tokuhisa, 1997, Disruption of the BcI6 gene results in an impaired germinal center formationJ. Exp. Med. 186,439–448.
A.L. Dent, J. Hu-Li, W.E. Paul, and L.M. Staudt, 1998, T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6Proc. Natl. Acad. Sci. USA 95,13823–13828.
L.M. Toney, G. Cattoretti, J.A. Graf, T. Merghoub, P.P. Pandolfi, R. Dalla-Favera B.H. Ye, and A.L. Dent, 2000, BCL-6 regulates chemokine gene transcription in macrophages. Nat. Immunol. 1214–220.
A.L. Shaffer, X. Yu, Y. He, J. Boldrick, E.P. Chan, and L.M. Staudt, 2000, BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle controlImmunity 13,199–212.
M.A. Blackman, M.A.TiggeS, M.E. Minie, and M.E. Koshland, 1986, A model system for peptide hormone action in differentiation: interleukin 2 induces a B lymphoma to transcribe the J chain geneCell 47,609–617.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fearon, D.T., Manders, P.M., Wagner, S.D. (2002). Bcl-6 Uncouples B Lymphocyte Proliferation from Differentiation. In: Gupta, S., Butcher, E., Paul, W. (eds) Lymphocyte Activation and Immune Regulation IX. Advances in Experimental Medicine and Biology, vol 512. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0757-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0757-4_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5226-6
Online ISBN: 978-1-4615-0757-4
eBook Packages: Springer Book Archive